Tags

Type your tag names separated by a space and hit enter

The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
PLoS Genet. 2012 Feb; 8(2):e1002488.PG

Abstract

Overexpression or mutation of α-Synuclein is associated with protein aggregation and interferes with a number of cellular processes, including mitochondrial integrity and function. We used a whole-genome screen in the fruit fly Drosophila melanogaster to search for novel genetic modifiers of human [A53T]α-Synuclein-induced neurotoxicity. Decreased expression of the mitochondrial chaperone protein tumor necrosis factor receptor associated protein-1 (TRAP1) was found to enhance age-dependent loss of fly head dopamine (DA) and DA neuron number resulting from [A53T]α-Synuclein expression. In addition, decreased TRAP1 expression in [A53T]α-Synuclein-expressing flies resulted in enhanced loss of climbing ability and sensitivity to oxidative stress. Overexpression of human TRAP1 was able to rescue these phenotypes. Similarly, human TRAP1 overexpression in rat primary cortical neurons rescued [A53T]α-Synuclein-induced sensitivity to rotenone treatment. In human (non)neuronal cell lines, small interfering RNA directed against TRAP1 enhanced [A53T]α-Synuclein-induced sensitivity to oxidative stress treatment. [A53T]α-Synuclein directly interfered with mitochondrial function, as its expression reduced Complex I activity in HEK293 cells. These effects were blocked by TRAP1 overexpression. Moreover, TRAP1 was able to prevent alteration in mitochondrial morphology caused by [A53T]α-Synuclein overexpression in human SH-SY5Y cells. These results indicate that [A53T]α-Synuclein toxicity is intimately connected to mitochondrial dysfunction and that toxicity reduction in fly and rat primary neurons and human cell lines can be achieved using overexpression of the mitochondrial chaperone TRAP1. Interestingly, TRAP1 has previously been shown to be phosphorylated by the serine/threonine kinase PINK1, thus providing a potential link of PINK1 via TRAP1 to α-Synuclein.

Authors+Show Affiliations

Department of Neurology, University Medical Center, RWTH Aachen, Germany.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22319455

Citation

Butler, Erin K., et al. "The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity." PLoS Genetics, vol. 8, no. 2, 2012, pp. e1002488.
Butler EK, Voigt A, Lutz AK, et al. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity. PLoS Genet. 2012;8(2):e1002488.
Butler, E. K., Voigt, A., Lutz, A. K., Toegel, J. P., Gerhardt, E., Karsten, P., Falkenburger, B., Reinartz, A., Winklhofer, K. F., & Schulz, J. B. (2012). The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity. PLoS Genetics, 8(2), e1002488. https://doi.org/10.1371/journal.pgen.1002488
Butler EK, et al. The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity. PLoS Genet. 2012;8(2):e1002488. PubMed PMID: 22319455.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity. AU - Butler,Erin K, AU - Voigt,Aaron, AU - Lutz,A Kathrin, AU - Toegel,Jane P, AU - Gerhardt,Ellen, AU - Karsten,Peter, AU - Falkenburger,Björn, AU - Reinartz,Andrea, AU - Winklhofer,Konstanze F, AU - Schulz,Jörg B, Y1 - 2012/02/02/ PY - 2011/04/07/received PY - 2011/12/02/accepted PY - 2012/2/10/entrez PY - 2012/2/10/pubmed PY - 2012/6/26/medline SP - e1002488 EP - e1002488 JF - PLoS genetics JO - PLoS Genet VL - 8 IS - 2 N2 - Overexpression or mutation of α-Synuclein is associated with protein aggregation and interferes with a number of cellular processes, including mitochondrial integrity and function. We used a whole-genome screen in the fruit fly Drosophila melanogaster to search for novel genetic modifiers of human [A53T]α-Synuclein-induced neurotoxicity. Decreased expression of the mitochondrial chaperone protein tumor necrosis factor receptor associated protein-1 (TRAP1) was found to enhance age-dependent loss of fly head dopamine (DA) and DA neuron number resulting from [A53T]α-Synuclein expression. In addition, decreased TRAP1 expression in [A53T]α-Synuclein-expressing flies resulted in enhanced loss of climbing ability and sensitivity to oxidative stress. Overexpression of human TRAP1 was able to rescue these phenotypes. Similarly, human TRAP1 overexpression in rat primary cortical neurons rescued [A53T]α-Synuclein-induced sensitivity to rotenone treatment. In human (non)neuronal cell lines, small interfering RNA directed against TRAP1 enhanced [A53T]α-Synuclein-induced sensitivity to oxidative stress treatment. [A53T]α-Synuclein directly interfered with mitochondrial function, as its expression reduced Complex I activity in HEK293 cells. These effects were blocked by TRAP1 overexpression. Moreover, TRAP1 was able to prevent alteration in mitochondrial morphology caused by [A53T]α-Synuclein overexpression in human SH-SY5Y cells. These results indicate that [A53T]α-Synuclein toxicity is intimately connected to mitochondrial dysfunction and that toxicity reduction in fly and rat primary neurons and human cell lines can be achieved using overexpression of the mitochondrial chaperone TRAP1. Interestingly, TRAP1 has previously been shown to be phosphorylated by the serine/threonine kinase PINK1, thus providing a potential link of PINK1 via TRAP1 to α-Synuclein. SN - 1553-7404 UR - https://www.unboundmedicine.com/medline/citation/22319455/The_mitochondrial_chaperone_protein_TRAP1_mitigates_α_Synuclein_toxicity_ L2 - https://dx.plos.org/10.1371/journal.pgen.1002488 DB - PRIME DP - Unbound Medicine ER -